Skip to content

Casey Delacy

NPI 1508218546ActiveIndividual· Nurse Practitioner, Primary Care· Chester, PA

Nurse Practitioner, Primary Care in Chester, Pennsylvania, licensed in PA, with an NPI issued in July 2016. Part D covered 1,209 prescriptions written in 2024, 78% of them generic. Neurocrine Biosciences, Inc. reported $27.37 in payments in 2025, mostly food and beverage.

Overview

NPI1508218546
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedJul 1, 2016
Last updated in NPPESJan 10, 2023
Certified by providerJan 5, 2023

Specialties and licenses

TaxonomyCodeLicenseState
Nurse Practitioner, Primary Care Primary363LP2300XSP016219PA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nurse Practitioner (PA)

Part D prescriptions in 2024

Prescriptions (claims)1,209 · 1,211 30-day fills
Patients93
Total drug cost$109,037
Generic share78% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$27.37 · 1 payment from 1 company
  • 2024$108.21 · 4 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Neurocrine Biosciences, Inc.$27.371

What the 2025 payments were for

  • Food and Beverage$27.37 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other primary care nurse practitioners in Chester

All primary care nurse practitioners in Pennsylvania